Blog
RSS FeedPosted by Michael Wonder on 19 Dec 2019
Request for information on lamotrigine brand change
9 December 2019 - The request, dated 15 November 2019, asked for all and any advice or information or guidance that ...
Posted by Michael Wonder on 19 Dec 2019
Soaring medication prices in remote Australian chemists have families going online
19 December 2019 - Residents living in outback Australia are paying more for some common medications than people living in ...
Posted by Michael Wonder on 18 Dec 2019
Pickering mother with cystic fibrosis pleads for ‘miracle drug’ to come to Canada
16 December 2019 - A Pickering mother fighting cystic fibrosis is calling for all levels of government and stakeholders to ...
Posted by Michael Wonder on 18 Dec 2019
Price disclosure 2020 April cycle outcomes summary
18 December 2019 - The summary of price disclosure price reductions for the 2020 April Cycle has now been published. ...
Posted by Michael Wonder on 18 Dec 2019
PBS Growth Hormone Program - 1 January 2020 listing changes
18 December 2019 - Changes to the Pharmaceutical Benefits Scheme restrictions for growth hormone treatment (adult use), which set out ...
Posted by Michael Wonder on 18 Dec 2019
Funding of vitamin A oral liquid
18 December 2019 - PHARMAC is pleased to announce that PHARMAC has approved the use of the Exceptional Circumstances framework ...
Posted by Michael Wonder on 18 Dec 2019
Proposal to fund mepolizumab for the treatment of severe refractory eosinophilic asthma
18 December 2019 - PHARMAC is seeking feedback on a proposal to fund mepolizumab (Nucala), a new treatment for severe ...
Posted by Michael Wonder on 17 Dec 2019
Comparison of PHARMAC with UK agency was misleading
17 December 2019 - The Broadcasting Standards Authority has upheld part of a complaint that an interview on Radio New ...
Posted by Michael Wonder on 17 Dec 2019
PHARMAC brand switch: man driving through Waterview Tunnel blacked out
18 December 2019 - An Auckland man had a seizure and blacked out as he drove through Auckland's Waterview Tunnel after ...
Posted by Michael Wonder on 17 Dec 2019
Calls for answers about PHARMAC delay after epilepsy deaths
17 December 2019 - The Opposition is calling for answers from the Government about why it took two weeks for ...
Posted by Michael Wonder on 17 Dec 2019
Report on the collection of under co-payment data 2018-19
17 December 2019 - The report on the collection of under co-payment data 2018-19 is now available. ...
Posted by Michael Wonder on 17 Dec 2019
Lamotrigine NPPA change
17 December 2019 - The request seeks all ‘communications’ between members of the PHARMAC senior leadership team, and in anticipation ...
Posted by Michael Wonder on 17 Dec 2019
Spinraza funding application reviewed by the Rare Disorders Subcommittee
17 December 2019 - PHARMAC has published the Rare Disorders Subcommittee meeting records which recommends Spinraza (nusinersen), a medication for ...
Posted by Michael Wonder on 16 Dec 2019
PHARMAC knew of epilepsy deaths for weeks but stayed silent
17 December 2019 - PHARMAC knew for more than two weeks that three deaths had been linked to its epilepsy ...
Posted by Michael Wonder on 16 Dec 2019
NICE u-turn backs NHS use of Veltassa
16 December 2019 - The National Institute for Health and Care Excellence has given its stamp of approval for NHS ...